Literature DB >> 20853876

Revision of the Structures of 1,5-Dihydroxy-3,8-epoxyvalechlorine, Volvaltrate B, and Valeriotetrate C from Valeriana jatamansi and V. officinalis.

Sheng Lin1, Yun-Heng Shen, Zhong-Xiao Zhang, Hui-Liang Li, Lei Shan, Run-Hui Liu, Xi-Ke Xu, Wei-Dong Zhang.   

Abstract

The structures of 1,5-dihydroxy-3,8-epoxyvalechlorine (1a) and volvaltrate B (6a), two new chlorinated iridoids isolated from Valeriana jatamansi and V. officinalis, respectively, were originally assigned on the basis of spectroscopic methods. Reinvestigation using X-ray analysis and chemical transformation revealed that the original assignment of H-7 in 1a and OH-8 in 6a should be inverted and that the structures should be revised to 1 and 6, respectively. Correspondingly, the structure of valeriotetrate C (7a) should be revised to 7. Volvaltrate B (6) showed cytotoxic activity against the lung adenocarcinoma (A549), metastatic prostate cancer (PC-3M), colon cancer (HCT-8), and hepatoma (Bel7402) cell lines, with IC50 values of 8.5, 2.0, 3.2, and 6.1 μM, respectively.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20853876     DOI: 10.1021/np100426j

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  3 in total

1.  Three new iridoids from the roots of Valeriana jatamansi.

Authors:  Jing Xu; Yuanqiang Guo; Da-qing Jin; Peng Zhao; Ping Guo; Tohru Yamakuni; Yasushi Ohizumi
Journal:  J Nat Med       Date:  2012-02-14       Impact factor: 2.343

2.  Valepotriates From the Roots and Rhizomes of Valeriana jatamansi Jones as Novel N-Type Calcium Channel Antagonists.

Authors:  Fa-Wu Dong; He-Hai Jiang; Liu Yang; Ye Gong; Cheng-Ting Zi; Dan Yang; Chen-Jun Ye; Huan Li; Jian Yang; Yin Nian; Jun Zhou; Jiang-Miao Hu
Journal:  Front Pharmacol       Date:  2018-08-13       Impact factor: 5.810

Review 3.  The potential of Valeriana as a traditional Chinese medicine: traditional clinical applications, bioactivities, and phytochemistry.

Authors:  Jianchun Li; Xiaoliang Li; Changfu Wang; Manli Zhang; Minhui Ye; Qiuhong Wang
Journal:  Front Pharmacol       Date:  2022-09-21       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.